Skip to content

Evaluation of Infection in Obstructing Urolithiasis

Evaluation of Infection in Obstructing Urolithiasis: A Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04332861
Acronym
eIOU
Enrollment
477
Registered
2020-04-03
Start date
2019-09-03
Completion date
2020-07-28
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Kidney Calculi, Kidney Stone, Sepsis, Urinary Tract Obstruction

Keywords

Kidney Stone, Kidney Calculi, Urinary Tract Obstruction, Infection, Sepsis

Brief summary

Obstructing urolithiasis can be life-threatening in the setting of urinary tract infection. The purpose of this study is to identify and validate risk factors and markers for the presence of infection and development of sepsis among patients with obstructing urolithiasis.

Detailed description

An obstructing stone and suspected urinary tract infection is an indication for drainage of the renal collecting system. In this setting, decompression with a ureteral stent or percutaneous nephrostomy (PCN) is associated with decreased mortality and both methods have similar efficacy. At the time of initial evaluation, it is sometimes uncertain whether infection is present, resulting in difficult management decisions. It is also difficult to identify infected patients at greatest risk of developing sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. There are currently no widely adopted criteria for the accurate diagnosis of infection in the setting of an obstructing stone. Abnormal vital signs, leukocytosis, and abnormal urinalysis are relied upon, but these findings are often indeterminate. Most studies to date addressing this problem have retrospectively evaluated associations of single variables with infection including pyuria and bacteriuria, or performance of sepsis screening tools such as the Sepsis-related Organ Failure Assessment (SOFA). More accurate diagnostic measures for infected obstructing urolithiasis and a better understanding of its natural history are needed in order to improve patient outcomes. While early recognition of patients at significant risk of developing sepsis is essential, treatment of patients who are not clinically infected with antibiotics and decompression procedures is unnecessarily morbid. Therefore, the investigators aim to develop and validate diagnostic criteria to predict development of life-threatening infection in a prospective observational fashion.

Interventions

OTHERInitial clinical and laboratory evaluation

Initial evaluation, prior to administration of any antibiotics if possible, includes history, physical exam, and labs including: * Urinalysis * Urine culture * Blood cultures * Complete blood count with differential * Comprehensive metabolic panel * Lactate * Procalcitonin * Other inflammatory markers

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Men and women 18 and older * Acute presentation of obstructing urolithiasis diagnosed on CT

Exclusion criteria

* Indwelling nephrostomy tubes or ureteral stents * Staghorn calculi or evidence of xanthogranulomatous pyelonephritis

Design outcomes

Primary

MeasureTime frameDescription
Urinary tract infection (positive urine culture)Within 24-72 hours of initial clinical and laboratory evaluationUrinary tract infection, defined as a positive urine culture
Intensive care unit admission and/or death due to sepsis during inpatient encounterOn average within 24-72 hours after initial clinical and laboratory evaluationIntensive care unit admission and/or death secondary to sepsis, occurring during the inpatient incounter.

Secondary

MeasureTime frameDescription
Bacteremia (at least one positive blood culture)Within 24-72 hours of initial clinical and laboratory evaluationBacteremia, defined as at least one positive blood culture
Pyonephrosis (drainage of pus from the involved kidney) during inpatient encounterOn average within 24-72 hours after initial clinical and laboratory evaluationPyonephrosis, defined as drainage of pus from the involved kidney at any point during the inpatient encounter

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026